103 related articles for article (PubMed ID: 7000132)
1. Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of antiplatelet agents.
Cattell V; Mehotra A
Br J Exp Pathol; 1980 Jun; 61(3):310-4. PubMed ID: 7000132
[TBL] [Abstract][Full Text] [Related]
2. Focal mesangial proliferative glomerulonephritis in the rat caused by Habu snake venom: the role of platelets.
Cattell V
Br J Exp Pathol; 1979 Apr; 60(2):201-8. PubMed ID: 444423
[TBL] [Abstract][Full Text] [Related]
3. Focal mesangial proliferative glomerulonephritis in the rat caused by habu snake venom. A morphologic study.
Cattell V; Bradfield JW
Am J Pathol; 1977 Jun; 87(3):511-24. PubMed ID: 869011
[TBL] [Abstract][Full Text] [Related]
4. Mesangial cell migration precedes proliferation in Habu snake venom-induced glomerular injury.
Barnes JL; Hevey KA; Hastings RR; Bocanegra RA
Lab Invest; 1994 Apr; 70(4):460-7. PubMed ID: 8176886
[TBL] [Abstract][Full Text] [Related]
5. Focal sclerosing glomerulonephritis: a kinetic evaluation of hemostasis and the effect of anticoagulant therapy: a controlled study.
Futrakul P; Poshyachinda M; Mitrakul C
Clin Nephrol; 1978 Nov; 10(5):180-6. PubMed ID: 729213
[TBL] [Abstract][Full Text] [Related]
6. [Mesangial proliferative changes and mesangiolysis. Habu-snake venom induced glomerular lesions of the kidney].
Min W
Nihon Ika Daigaku Zasshi; 1989 Feb; 56(1):39-50. PubMed ID: 2732303
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of habu venom-induced glomerular lesions: potential role for platelet secretory proteins.
Barnes JL
J Lab Clin Med; 1989 Aug; 114(2):200-6. PubMed ID: 2754307
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet therapy.
Sloan RW
Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition for glomerulonephritis-induced glomerulosclerosis in rats is linked to chromosome 1.
Ijpelaar DH; Schulz A; Aben J; van der Wal A; Bruijn JA; Kreutz R; de Heer E
Physiol Genomics; 2008 Oct; 35(2):173-81. PubMed ID: 18682577
[TBL] [Abstract][Full Text] [Related]
11. The mesangial cell in glomerulonephritis. II. Mesangial proliferation caused by Habu snake venom in the rat.
Bradfield JW; Cattell V; Smith J
Lab Invest; 1977 May; 36(5):487-92. PubMed ID: 325293
[No Abstract] [Full Text] [Related]
12. Quinacrine mustard: a fluorescent platelet label. In vitro studies and in vivo localisation in Habu venom glomerulonephritis in rats.
Bates SA; Cattell V
Thromb Res; 1980 Nov; 20(3):315-24. PubMed ID: 6970999
[No Abstract] [Full Text] [Related]
13. Controlled trial of antiplatelet agents in mesangial IgA glomerulonephritis.
Chan MK; Kwan SY; Chan KW; Yeung CK
Am J Kidney Dis; 1987 May; 9(5):417-21. PubMed ID: 3555016
[TBL] [Abstract][Full Text] [Related]
14. Glomerular localization of platelet secretory proteins in mesangial proliferative lesions induced by habu snake venom.
Barnes JL
J Histochem Cytochem; 1989 Jul; 37(7):1075-82. PubMed ID: 2659663
[TBL] [Abstract][Full Text] [Related]
15. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of chronic proliferative glomerulonephritis using acetylsalicylic acid and dipyridamole].
Knotková V; Petrů I; Nĕmecek K; Cieslar P; Pelèska J; Jáchymová M; Pick P; Tomasy M
Cas Lek Cesk; 1989 Jun; 128(26):814-8. PubMed ID: 2507156
[TBL] [Abstract][Full Text] [Related]
17. A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis.
Futrakul P
Int J Pediatr Nephrol; 1980 Mar; 1(1):18-21. PubMed ID: 7343523
[TBL] [Abstract][Full Text] [Related]
18. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
Donadio JV; Anderson CF; Mitchell JC; Holley KE; Ilstrup DM; Fuster V; Chesebro JH
N Engl J Med; 1984 May; 310(22):1421-6. PubMed ID: 6371535
[TBL] [Abstract][Full Text] [Related]
19. [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].
Duclos J
Rev Med Chil; 1993 Mar; 121(3):286-91. PubMed ID: 8248641
[TBL] [Abstract][Full Text] [Related]
20. Effect of dipyridamole and prostacyclin on rabbit platelet adherence in vitro and in vivo.
Groves HM; Kinlough-Rathbone RL; Cazenave JP; Dejana E; Richardson M; Mustard JF
J Lab Clin Med; 1982 Apr; 99(4):548-58. PubMed ID: 7038012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
